MedTrace Logo

Quality of Life Among Survivors of Hodgkin Lymphoma

NCT00598728 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 255

Last updated 2016-04-27

No results posted yet for this study

Summary

The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.

Conditions

  • Hodgkin's Disease

Interventions

BEHAVIORAL

Quality of Life Questionaires

A patient questionnaire, which includes questions on medical morbidities and QOL, will be mailed to participants.

Sponsors & Collaborators

Principal Investigators

  • David Straus, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00598728 on ClinicalTrials.gov